Date published: 2025-12-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

C1orf83 Inhibitors

The chemical class identified as C1orf83 Inhibitors comprises a range of compounds selected for their potential to modulate the activity of C1orf83, a protein involved in transcription elongation. This class is not defined by a shared chemical structure but by the shared objective of influencing C1orf83's function within the transcription process. These inhibitors operate through various mechanisms, reflecting the complexity of transcription elongation and the role of C1orf83 in this essential cellular process. The inhibitors in this class include those that can disrupt the interaction of C1orf83 with key components of the transcription machinery, as well as those that influence the broader environment in which C1orf83 operates, such as chromatin structure and transcriptional regulation.

The inhibitors targeting C1orf83 function by interfering with the transcription elongation process at different stages. Some achieve this by hindering the interaction between C1orf83 and RNA Polymerase II, thereby directly impacting the elongation phase of mRNA synthesis. Others work by modulating the chromatin landscape, affecting the accessibility of DNA for transcription, and indirectly influencing the role of C1orf83. Additionally, certain inhibitors in this class focus on altering the phosphorylation status of transcription-related proteins, which is a critical regulatory mechanism in transcription elongation. This approach allows for the indirect modulation of C1orf83's activity by changing the dynamics of transcription initiation and elongation processes. The C1orf83 Inhibitors class represents a strategic approach to manipulating a specific protein's function by intervening in broader biological processes and pathways. This class underscores the intricate relationship between chemical entities and biological systems, showcasing the depth of understanding required to manipulate specific protein functions within complex biological processes. It highlights the potential of targeted molecular intervention in studying and influencing key aspects of cellular function, particularly transcription, a fundamental process critical to all cellular activities. By focusing on the modulation of transcription elongation, this class of inhibitors opens up avenues for research into the mechanisms of gene expression regulation and the role of specific proteins like C1orf83 in these processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

Alpha-Amanitin inhibits RNA Polymerase II, potentially disrupting the transcription elongation process in which C1orf83 is involved by hindering the elongation phase of mRNA synthesis.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$42.00
$185.00
$310.00
$650.00
6
(1)

DRB inhibits transcription elongation by affecting the activity of RNA Polymerase II, which could indirectly impact C1orf83's function in facilitating transcription elongation.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Triptolide inhibits the transcriptional activity by affecting RNA Polymerase II, potentially disrupting C1orf83's role in the transcription elongation process.

Flavopiridol Hydrochloride

131740-09-5sc-207687
10 mg
$311.00
(2)

Flavopiridol Hydrochloride inhibits CDK9, a key regulator of transcription elongation, potentially affecting C1orf83's function by altering the phosphorylation status of RNA Polymerase II.

Rocaglamide

84573-16-0sc-203241
sc-203241A
sc-203241B
sc-203241C
sc-203241D
100 µg
1 mg
5 mg
10 mg
25 mg
$270.00
$465.00
$1607.00
$2448.00
$5239.00
4
(1)

Rocaglamide inhibits translation initiation and, by altering protein synthesis, might indirectly affect C1orf83's function in transcription.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D intercalates into DNA, potentially inhibiting transcription processes by blocking RNA Polymerase movement, which would affect C1orf83's role in transcription elongation.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A, a histone deacetylase inhibitor, can affect chromatin structure, potentially impacting C1orf83's function in transcription elongation by altering DNA accessibility.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$88.00
$208.00
24
(2)

MS-275 targets chromatin readers, which might influence transcription elongation activities involving C1orf83 by altering chromatin dynamics.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Suberoylanilide Hydroxamic Acid, by inhibiting histone deacetylase, can affect chromatin structure and indirectly impact C1orf83's role in transcription elongation.